Abstract
Introduction: Lung cancer is the most prevalent malignancy worldwide and accounts for more cancer-related deaths than any other disease site, despite advances in early detection and management. Radiation therapy is used in the management of all stages of non-small cell lung cancer, including adenocarcinoma in situ/minimally invasive adenocarcinoma, and small cell lung cancer.
Conclusion: This article provides a brief current overview of literature pertaining to the role of radiation therapy in the management of lung cancer.
Keywords: Radiotherapy, non-small cell lung cancer, small cell lung cancer, lung cancer, prognosis, adenocarcinoma.
Current Cancer Therapy Reviews
Title:Current Overview of Lung Cancer from Pathology, Screening to Treatment
Volume: 14 Issue: 2
Author(s): Stacey Davidson and Edward Yu*
Affiliation:
- Department of Oncology, Division of Radiation Oncology, Western University, London Regional Cancer Program, London, Ontario, ON N6A 5W9,Canada
Keywords: Radiotherapy, non-small cell lung cancer, small cell lung cancer, lung cancer, prognosis, adenocarcinoma.
Abstract: Introduction: Lung cancer is the most prevalent malignancy worldwide and accounts for more cancer-related deaths than any other disease site, despite advances in early detection and management. Radiation therapy is used in the management of all stages of non-small cell lung cancer, including adenocarcinoma in situ/minimally invasive adenocarcinoma, and small cell lung cancer.
Conclusion: This article provides a brief current overview of literature pertaining to the role of radiation therapy in the management of lung cancer.
Export Options
About this article
Cite this article as:
Davidson Stacey and Yu Edward *, Current Overview of Lung Cancer from Pathology, Screening to Treatment, Current Cancer Therapy Reviews 2018; 14 (2) . https://dx.doi.org/10.2174/1573394714666180208141456
DOI https://dx.doi.org/10.2174/1573394714666180208141456 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Neuroinformatics Study Describing Molecular Interaction of Cisplatin with Acetylcholinesterase: A Plausible Cause for Anticancer Drug Induced Neurotoxicity
CNS & Neurological Disorders - Drug Targets Associating Paracrine Communication to Regenerative Medicine: Search Strategies & Major Trends in Scientific and Patent Production
Recent Patents on Regenerative Medicine Implications of Nanotechnology in Healthcare
Nanoscience & Nanotechnology-Asia A New Synthetic Spiroketal: Studies on Antitumor Activity on Murine Melanoma Model In Vivo and Mechanism of Action In Vitro
Anti-Cancer Agents in Medicinal Chemistry Increased Expression of Matrix Metalloproteinases Mediates Thromboxane A2-Induced Invasion in Lung Cancer Cells
Current Cancer Drug Targets Irinotecan for Treatment of Childhood Cancers: A Promising Therapeutic Partner
Current Cancer Therapy Reviews RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Current Medicinal Chemistry Determination of 7,12-Dimethylbenz[a]Anthracene in Orally Treated Rats by High-Performance Liquid Chromatography and Transfer Stripping Voltammetry
Combinatorial Chemistry & High Throughput Screening Evaluation of A Novel GLP-1R Ligand for PET Imaging of Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Microbiome in Chronic Obstructive Pulmonary Disease: Role of Natural Products Against Microbial Pathogens
Current Medicinal Chemistry T Cell Tuning for Tumour Therapy: Enhancing Effector Function and Memory Potential of Therapeutic T cells
Current Gene Therapy Proteomics Using Mammospheres as a Model System to Identify Proteins Deregulated in Breast Cancer Stem Cells
Current Molecular Medicine Epigenetic Biomarkers for Risk Assessment of Particulate Matter Associated Lung Cancer
Current Drug Targets An Antileukemic Glutaminase Free L-Asparaginase from Bacillus brevis
Current Biotechnology Genetic Determinants of Athletic Performance
Recent Patents on DNA & Gene Sequences Bee Venom: Its Potential Use in Alternative Medicine
Anti-Infective Agents Cardiovascular Biology of Interleukin-6
Current Pharmaceutical Design Lapatinib as a Chemotherapeutic Drug
Recent Patents on Anti-Cancer Drug Discovery Integrins: Novel Therapeutic Targets for Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Angiotensin-Converting Enzymes (ACE and ACE2) as Potential Targets for Malignant Epithelial Neoplasia: Review and Bioinformatics Analyses Focused in Oral Squamous Cell Carcinoma
Protein & Peptide Letters